In the final framework, there was a commitment of $4 million, I believe, to CIHR for research on diagnosis, treatment, and the ongoing chronic effects of Lyme disease.
There was a question about NSERC at the last meeting and why NSERC wasn't part of the funding award. Can you comment on CIHR versus NSERC, and the decisions around the research funding?